1. Home
  2. CHPT vs ANIK Comparison

CHPT vs ANIK Comparison

Compare CHPT & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ChargePoint Holdings Inc.

CHPT

ChargePoint Holdings Inc.

HOLD

Current Price

$5.54

Market Cap

184.9M

ML Signal

HOLD

Logo Anika Therapeutics Inc.

ANIK

Anika Therapeutics Inc.

HOLD

Current Price

$14.84

Market Cap

198.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CHPT
ANIK
Founded
2007
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
184.9M
198.9M
IPO Year
2019
1996

Fundamental Metrics

Financial Performance
Metric
CHPT
ANIK
Price
$5.54
$14.84
Analyst Decision
Hold
Buy
Analyst Count
9
1
Target Price
$9.25
$17.00
AVG Volume (30 Days)
745.8K
57.4K
Earning Date
06-03-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
80.16
EPS
N/A
N/A
Revenue
$411,224,000.00
$112,819,000.00
Revenue This Year
$4.18
$5.98
Revenue Next Year
$16.63
$7.42
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.58
$7.90
52 Week High
$12.62
$16.24

Technical Indicators

Market Signals
Indicator
CHPT
ANIK
Relative Strength Index (RSI) 37.91 57.13
Support Level $4.44 $13.91
Resistance Level $7.00 $15.93
Average True Range (ATR) 0.68 0.50
MACD -0.26 0.05
Stochastic Oscillator 12.31 95.80

Price Performance

Historical Comparison
CHPT
ANIK

About CHPT ChargePoint Holdings Inc.

ChargePoint Holdings Inc designs, develops, and markets networked electric vehicle charging system infrastructure and cloud-based services that enable charging systems owners, charge point operators, to manage their Networked Charging Systems, and to enable drivers to locate, reserve and authenticate Networked Charging Systems and to transact EV charging sessions on those systems. The company's hardware product lineup includes solutions across home, commercial, and fast-charging applications. The company derives the majority of its revenue from the United States.

About ANIK Anika Therapeutics Inc.

Anika Therapeutics Inc operates in the OA Pain Management and regenerative solutions space, focusing on early intervention orthopedics. The company leverages proprietary hyaluronic acid (HA) technology to develop differentiated products and provides products and services. Its OA Pain Management products include Orthovisc, Monovisc, and Cingal. Monovisc and Orthovisc are single- and multi-injection HA viscosupplement products indicated for pain relief from OA conditions and are generally administered to patients in an office setting. In the United States, Monovisc and Orthovisc are marketed exclusively by Johnson & Johnson MedTech. It generates maximum revenue from the OEM Channel and derives the majority of its revenue from the United States, with a presence in Europe and other countries.

Share on Social Networks: